Teva opposes Corcept's summary judgment motion in US antitrust litigation
MLex Summary: Teva Pharmaceuticals urged a California federal judge to deny Corcept Therapeutics' motion for summary judgment in their antitrust dispute. Teva alleges that Corcept imposed a "one-of-a-kind exclusive-dealing agreement" on...To view the full article, register now.
Already a subscriber? Click here to view full article